Detection of Chromosomal Translocations :in Leukemia-Lymphoma Cells by Polymerase Chain Reaction

References

• Rabbitts T. H., Behm T. Structural anti functional chimerism results from chromosomal translocation in lymphoid tumors. Adv. Immunol. 1991; 50: 119–146
   PubMed Web of Science ®Google Scholar
• Boxer L. M. The role of oncogenes in hematologic malignancies. Annu. Rev. Med. 1994; 45: 1–11
   PubMed Web of Science ®Google Scholar
• Cline M. J. The molecular basis of leukemia. N. Engl. J. Med. 1994; 330: 328–336
   PubMed Web of Science ®Google Scholar
• Bishop J. M. Molecular themes in oncogenesis. Cell 1991; 64: 235–248
   PubMed Web of Science ®Google Scholar
• Hunter T. Cooperation between oncogenes. Cell 1991; 64: 249–270
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. Tumor suppressor genes. Science 1991; 254: 1138–1146
   PubMed Web of Science ®Google Scholar
• Cleary M. L. Oncogenic conversion of transcription factors by chromosomal translocations. Cell 1991; 66: 619–622
   PubMed Web of Science ®Google Scholar
• Rabbitts T. H. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 1991; 67: 641–644
   PubMed Web of Science ®Google Scholar
• Solomon E., Borrow J., Goddard A. D. Chromosome aberrations and cancer. Science 1991; 254: 1153–1160
   PubMed Web of Science ®Google Scholar
• Gauwerky C. E., Croce C. M. Chromosomal translocations in leukaemia. Semin. Cancer Biol. 1993; 4: 333–340
   PubMed Web of Science ®Google Scholar
• Hunger S. P., Cleary M. L. Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukaemia. Semin. Cancer Biol. 1993; 4: 387–399
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Bcl-2 initiates a new category of onco-genes: Regulators of cell death. Blood 1992; 80: 879–886
   PubMed Web of Science ®Google Scholar
• Sánchez-Garcia I., Rabbitts T. H. LIM domain proteins in leukaemia and development. Semin. Cancer Biol. 1993; 4: 349–358
   PubMed Web of Science ®Google Scholar
• Boehm T., Rabbitts T. H. The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors. FASEB J. 1989; 3: 2344–2359
   PubMed Web of Science ®Google Scholar
• Cory S. Activation of cellular oncogenes in hematopoietic cells by chromosome translocation. Adv. Cancer Res. 1986; 47: 189–234
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu. Rev. Immunol. 1992; 10: 785–807
   PubMed Web of Science ®Google Scholar
• Baron B. W., Nucifora G., McCabe N., Espinosa R., III, Le Beau M. M., McKeithan T. W. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32)and t(3;22)(q27;q11) in B-cell lymphomas. Proc. Natl. Acad. Sci. USA. 1993; 90: 5262–5266
   PubMed Web of Science ®Google Scholar
• Kerckaert J. P., Deweindt C., Tilly H., Quief S., Lecocq G., Bastard C. LAZ3, a novel zinc-finger encoded gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nature Genet. 1993; 5: 66–70
   PubMed Web of Science ®Google Scholar
• Miki T., Kawamata N., Arai A., Ohashi K., Nakamura Y., Kato A, Hirosawa S., Aoki N. Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood 1994; 83: 217–222
   PubMed Web of Science ®Google Scholar
• Ye B. H., Lista F., Lo Coco F., Knowles D. M., Offit K., Chaganti R. S. K., Dalla-Favera R. Alterations of a zinc-finger encoding gene, BCL6, in diffuse large-cell lymphoma. Science 1993; 262: 747–750
   PubMed Web of Science ®Google Scholar
• Ye B. H., Rao P. H., Chaganti R. S. K., Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 1993; 53: 2732–2735
   PubMed Web of Science ®Google Scholar
• Grimaldi J. C., Meeker T. C. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene. Blood 1989; 73: 2081–2085
   PubMed Web of Science ®Google Scholar
• Dalla-Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Croce C. M. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 1982; 79: 7824–7827
   PubMed Web of Science ®Google Scholar
• Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytomacells. Proc. Natl. Acad. Sci. USA 1982; 79: 7837–7841
   PubMed Web of Science ®Google Scholar
• Croce C. M., Nowell P. C. Molecular basis of human B cell neoplasia. Blood 1985; 65: 1–7
   PubMed Web of Science ®Google Scholar
• Gauwerky C. E., Huebner K., Isobe M., Nowell P. C., Croce C. M. Activation of MYC in a masked t(8; 17) translocation results in an aggressive B-cell leukemia. Proc. Natl. Acad. Sci. USA 1989; 86: 8867–8871
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Henglein B., Groitl P., Lipp M., Bishop J. M. Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1989; 86: 3257–3260
   PubMed Web of Science ®Google Scholar
• Neri A., Chang C. C., Lombardi L., Salina M., Corradini P., Maiolo A. T., Chaganti R. S. K., Dalla-Favera R. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homoglous to NF-κB p50. Cell 1991; 67: 1075–1087
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Yunis J., Onorato-Showe L., Erikson J., Nowell P. C., Croce C. M. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 1984; 224: 1403–1406
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Jaffe E., Cossman J., Gorham J., Nowell P. C., Croce C. M. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985; 315: 340–343
   PubMed Web of Science ®Google Scholar
• Motokura T., Bloom T., Kim H. G., Juppner H., Ruderman J. V., Kronenberg H. M., Arnold A. A novel cyclin encoded by a bcl I-linked candidate oncogene. Nature 1991; 350: 512–515
   PubMed Web of Science ®Google Scholar
• Withers D. A., Harvey R. C., Faust J. B., Melnyk O., Carey K., Meeker T. C. Characterization of a candidate bcl-1 gene. Mol. Cell. Biol. 1991; 11: 4846–4853
   PubMed Web of Science ®Google Scholar
• Rosenberg C. L., Wong E., Petty E. M., Bale A. E., Tsujimoto Y., Harris N. L., Arnold A. PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA 1991; 88: 9638–9642
   PubMed Web of Science ®Google Scholar
• Raffeld M., Jaffe E. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 1991; 78: 259–263
   PubMed Web of Science ®Google Scholar
• Akao Y., Seto M., Takahashi T., Kubonishi I., Miyoshi I., Nakazawa S., Tsujimoto Y., Croce C. M., Ueda R. Molecular cloning of the chromosomal breakpoint of a B-cell lymphoma with the t(11;14)(q23;q32) translocation. Cancer Res. 1991; 51: 1574–1576
   PubMed Web of Science ®Google Scholar
• Lu D., Yunis J. J. Cloning, expression and localization of an RNA helicase gene from a human lymphoid cell line with chromosomal breakpoint 11q23.3. Nucleic Acid Res. 1992; 20: 1967–1972
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Finger L. R., Yunis J., Nowell P. C., Croce C. M. Cloning of the chromosome breakpoint of neoplas-tic B cells with the t(14;18) chromosome translocation. Science 1984; 226: 1097–1099
   PubMed Web of Science ®Google Scholar
• Bakhshi A., Jensen J. P., Goldman P., Wright J. J., McBride O. W., Epstein A. L., Korsmeyer S. J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899–906
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Sklar J. Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 1985; 82: 7439–7443
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J., Shutter J. R., Veis D. J., Merry D. E., Oltvai Z. N. Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 1993; 4: 327–332
   PubMed Web of Science ®Google Scholar
• Rimokh R., Gadoux M., Berthéas M. F., Berger F., Garoscio M., Deléage G., Germain D., Magaud J. P. FVT-I, a novel human transcription unit affected by variant translocation t(2;18)(p11;q21) of follicular lymphoma. Blood 1993; 81: 136–142
   PubMed Web of Science ®Google Scholar
• McKeithan T. W., Rowley J. D., Shows T. B., Diaz M. O. Cloning of the chromosome translocation breakpoint junction of the t(14; 19) in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 1987; 84: 9257–9260
   PubMed Web of Science ®Google Scholar
• Ohno H., Takimoto G., McKeithan T. W. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 1990; 60: 991–997
   PubMed Web of Science ®Google Scholar
• Tycko B., Smith S. D., Sklar J. Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia. J. Exp. Med. 1991; 174: 867–873
   PubMed Web of Science ®Google Scholar
• Begley C. G., Aplan P. D., Davey M. P., Nakahara K., Tchorz K., Kurtzberg J., Hershfield M. S., Haynes B. F., Cohen D. I., Waldmann T. A., Kirsch I. R. Chromosomal translocation in a human leukemic stem-cell line disriupts the T-cell antigen receptor δ-chain diversity region and results, in a previously unreported fusion transcript. Proc. Natl. Acad. Sci. USA 1989; 86: 2031–2035
   PubMed Web of Science ®Google Scholar
• Brown L., Cheng J. T., Chen Q., Siciliano M. J., Crist W., Buchanan G., Baer R. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 1990; 9: 3343–3351
   PubMed Web of Science ®Google Scholar
• Finger L. B., Kagan J., Christopher G., Kurtzberg J., Hershfield M. S., Nowell P. C., Croce C. M. Involvement of the TCL5 gene on chromosome 1 in T-cell leukemia and melanoma. Proc. Natl. Acad. Sci. USA 1989; 86: 5039–5043
   PubMed Web of Science ®Google Scholar
• Fitzgerald T. J., Neale G. A. M., Raimondi S. C., Goorha R. M. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-β chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35). Blood 1991; 78: 2686–2695
   PubMed Web of Science ®Google Scholar
• Aplan P. D., Raimondi S. C., Kirsch I. R. Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia. J. Exp. Med. 1992; 176: 1303–1310
   PubMed Web of Science ®Google Scholar
• Baer R. TAL1, TAL2 and LYL1: A family of basic helix-loop-helix proteins implicated in T cell mute leukaemia. Semin. Cancer Biol. 1993; 4: 341–347
   PubMed Web of Science ®Google Scholar
• Xia Y., Brown L., Yang C. Y. C., Tsan J. T., Siciliano M., Espinosa R., III, Le Beau M. M., Baer R. J. TAL2, a helix-loop-helix gene activated by the (7;9(q34;q32) translocation in human T-cell leukemia. Proc. Natl. Acad. Sci. USA 1991; 88: 11416–11420
   PubMed Web of Science ®Google Scholar
• Reynolds T. C., Smith S. D., Sklar J. Analysis of DNA surrounding the breakpoints of chromosomal translocations involving the β T cell receptor gene in human lymphoblastic neoplasms. Cell 1987; 50: 107–117
   PubMed Web of Science ®Google Scholar
• Tycko B., Reynolds T. C., Smith S. D., Sklar J. Consistent breakage between consensus recombinase heptamers of chromosome 9 DNA in a recurrent chromosomal translocation of human T cell leukemia. J. Exp. Med. 1989; 169: 369–377
   PubMed Web of Science ®Google Scholar
• Ellisen L. W., Bird J., West D. C., Soreng A. L., Reynolds T. C., Smith S. D., Sklar J. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649–661
   PubMed Web of Science ®Google Scholar
• Cleary M. L., Mellentin J. D., Spies J., Smith S. D. Chromosomal translocation involving the β T cell receptor gene in acute leukemia. J. Exp. Med. 1988; 167: 682–687
   PubMed Web of Science ®Google Scholar
• Mellentin J. D., Smith S. D., Cleary M. L. lyl-l, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 1989; 58: 77–83
   PubMed Web of Science ®Google Scholar
• McKeithan T. W., Shima E. A., Le Beau M. M., Minowada J., Rowley J. D., Diaz M. O. Molecular cloning of the breakpoint junction of a human chromosomal 8; 14 translocation involving the T-cell receptor α-chain gene and sequences on the 3′ side of. MYC. Proc. Natl. Acad. Sci. USA 1986; 83: 6636–6640
   PubMed Web of Science ®Google Scholar
• Finger L. R., Huebner K., Cannizzaro L. A., McLeod K., Nowell P. C., Croce C. M. Chromosomal translocation in T-cell leukemia line HUT 78 results in a MYC fusion transcript. Proc. Natl. Acad. Sci. USA 1988; 85: 9158–9162
   PubMed Web of Science ®Google Scholar
• Zutter M., Hockett R. D., Roberts C. W. M., McGuire E. A., Bloomstone J., Morton C. C., Deaven L. L., Crist W. M., Carroll A. J., Korsmeyer S. J. The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the y T-cell receptor with TCL3, a conserved and activated locus at 10q24. Proc. Natl. Acad. Sci. USA 1990; 87: 3161–3165
   PubMed Web of Science ®Google Scholar
• Hatano M., Roberts C. W. M., Minden M., Crist W. M., Korsmeyer S. J. Deregulation of a homeobox gene, hox11, by the t(10; 14) in T cell leukemia. Science 1991; 253: 79–82
   PubMed Web of Science ®Google Scholar
• Kennedy M. A., Gonzalez-Sarmiento R., Kees U. R., Lampert F., Dear N., Boehm T., Rabbitts T. H. HOX11, a home-obox-containing T-cell oncogene on human chromosome 10q24. Proc. Natl. Acad. Sci. USA. 1991; 88: 8900–8904
   PubMed Web of Science ®Google Scholar
• Dear T. N., Sanchez-Garcia I., Rabbitts T. H. The HOX11 gene encodes a DNA-binding nuclear transcription factor belonging to adistinct family of homeobox genes. Proc. Natl. Acad. Sci. USA 1993; 90: 4431–4435
   PubMed Web of Science ®Google Scholar
• McGuire E. A., Hockett R. D., Pollock K. M., Rartholdi M. F., O'Brien S. J., Korsmeyer S. J. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-l, a gene encoding a potential zinc finger protein. Mol. Cell. Biol. 1989; 9: 2124–2132
   PubMed Web of Science ®Google Scholar
• Boehm T., Foroni L., Kaneko Y., Perutz M. F., Rabbitts T. H. The rhombotin family of cysteine-rich LIM-domain oncogenes: Distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl. Acad. Sci. USA 1991; 88: 4367–4371
   PubMed Web of Science ®Google Scholar
• Royer-Pokora B., Loos U., Ludwig W. D. TTG-2, a new gene encoding a c:ysteine-rich protein with, the: LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 1991; 6: 1887–1883
   PubMed Web of Science ®Google Scholar
• Baer R., Chen K. C., Smith S. D., Rabbitts T. H. Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors. Cell 1985; 43: 705–713
   PubMed Web of Science ®Google Scholar
• Croce C. M., Isobe M., Palumbo A., Puck J., Ming J., Tweardy D., Erikson J., Davis M., Rovera G. Gene for α-chain of human T-cell receptor: Location on chromosome 14 region involved in T-cell neoplasms. Science 1985; 227: 1044–1047
   PubMed Web of Science ®Google Scholar
• Denny C. T., Yoshikaii Y., Mak T. W., Smith S. D., Hollis G. F., Kirsch I. R. A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between irnmunoglobulin and T-cell receptor loci. Nature 1986; 320: 549–551
   PubMed Web of Science ®Google Scholar
• Davey M. P., Bertness V., Nakahara K., Johnson J. P., McBride O. W., Waldmann T. A., Kirsch I. R. Juxtaposition of the T-cell receptor α-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;1.4 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia. Proc. Natl. Acad. Sci. USA 1981b; 85: 9287–9291
   Web of Science ®Google Scholar
• Russo G., Isobe M., Pegoraro L., Finan J., Nowell P. C., Croce C. M. Molecular analysis of a t(7; 14)(q35;q32) chromosome translocation in a T cell leukemia of a patient with ataxia telangiectasia. Cell 1988; 53: 137–144
   PubMed Web of Science ®Google Scholar
• Stern M. H., Soulier I., Rosenzwajg M., Nakahara K., Canki-Klain N., Aurias A., Sigaux F., Kirsch I. R. MTCP-1: A novel gene on the human chromosome Xq28 translocated to the T cell receptor α/γ locus in mature T cell proliferations. Oncogene 1993; 8: 2475–2483
   PubMed Web of Science ®Google Scholar
• Thick J., Mak Y. F., Metcalfe J., Beatty D., Taylor A. M. R. A gene on chromosome Xq28 associalted wi th T-cell pro-lymphocytic leukemia iin two patients with ataxia telangiectasia. Leukemia 1994; 8: 564–573
   PubMed Web of Science ®Google Scholar
• Cimino G., Moir D. T., Canaani O., Williams K., Crist W. M., Katzav S., Cannizzaro L., Lange B., Nowell P. C., Croce C. M., Canaani E. Cloning of ALL-l, the locus involved in leukemias with the t(4;11)(q21:q23), t(9;11)(p22:q23), and t(11;19)(q23:p13) chromosome translocations. Cancer Res. 1991; 51: 6712–6714
   PubMed Web of Science ®Google Scholar
• Ziemin-van der Poel S., McCabe N. R., Gill H. I., Espinosa R., III, Patel Y., Harden A., Rubinelli P., Smith S. D., Le Beau M. M., Rowley J. D., Diaz M. O. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocalions associated with human leukemias. Proc. Natl. Acad. Sci. USA 1991; 88: 10735–10739
   PubMed Web of Science ®Google Scholar
• Djabali M., Selleri L., Parry P., Bower M., Young B. D., Evans G. A. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nature Genet. 1992; 2: 113–118
   PubMed Web of Science ®Google Scholar
• McCabe N. R., Burnett R. C., Gill H. J., Thirman M. J., Mbangkollo D., Kipiniak M., van Melle E., Ziemin-van der Poel S., Rowley J. D., Diaz M. O. Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 transllocations. Proc. Natl. Acad. Sci. USA 1992; 89: 11794–11798
   PubMed Web of Science ®Google Scholar
• Parry P., Djabali M., Bower M., Khristich J., Waterman M., Gibbons B., Young B. D., Evans G. Structure and expression of the human trithorax-like gene 1 involved in acute leukemias. Proc. Natl. Acad. Sci. USA 1993; 90: 4738–4742
   PubMed Web of Science ®Google Scholar
• Rowley J. D. Rearrangements involving chromosome band 11q23 in acute leukaemia. Semin. Cancer Biol. 1993; 4: 377–385
   PubMed Web of Science ®Google Scholar
• Bernard O. A., Mauchauffe M., Mecucci C., Van den Berghe H., Berger R. A novel gene, AF-1p, fused to HRX in t(1; 11)(p32;q23), is not related to AF-4, AF-9 nor ENL. Oncogene 1994; 9: 1039–1045
   PubMed Web of Science ®Google Scholar
• Mellentin J. D., Murre C., Donlon T. A., McCaw P. S., Smith S. D., Carroll A. J., McDonald M. E., Baltimore D., Cleary M. L. The gene for enhancer binding proteins E12/E47 lies at the (1;19) breakpoint in acute leukemias. Science 1989; 246: 379–382
   PubMed Web of Science ®Google Scholar
• Kamps M. P., Murre C., Sun X. H., Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990; 60: 547–555
   PubMed Web of Science ®Google Scholar
• Nourse J., Mellentin J. D., Galili N., Wilkinson J., Stanbridge E., Smith S. D., Cleary M. L. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990; 60: 535–545
   PubMed Web of Science ®Google Scholar
• Bullrich F., Morris S. W., Hummel M., Pileri S., Stein H., Croce C. M. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res. 1994; 54: 2873–2877
   PubMed Web of Science ®Google Scholar
• Morris S. W., Kirstein M. N., Valentine M. B., Dittmer K. G., Shapiro D. N., Saltman D. L., Look A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284
   PubMed Web of Science ®Google Scholar
• Fichelson S., Dreyfus F., Berger R., Melle J., Bastard C., Miclea J. M., Gisselbrecht S. Evi-1 expression in leukemic patients with rearrangements of the 3Q25-Q28 chromosomal region. Leukemia 1992; 6: 93–99
   PubMed Web of Science ®Google Scholar
• Morishita K., Parganas E., Willman C. L., Whittaker M. H., Drabkin H., Oval J., Taetle R., Valentine M. B., Ihle J. N. Activation of EVII gene expression in human acute myelogenous leukemias by translocations spanning 300–400 kilobases on chromosome band 3q26. Proc. Natl. Acad. Sci. USA 1992; 89: 3937–3941
   PubMed Web of Science ®Google Scholar
• Levy E. R., Parganas E., Morishita K., Fichelson S., James L., Oscier D., Gisselbrecht S., Ihle J. N., Buckle V. J. DNA rearrangements proximal to the EVII locus associated with the 3q21q26 syndrome. Blood 1994; 83: 1348–1354
   PubMed Web of Science ®Google Scholar
• Yoneda N., Look A. T., Kirstein M. N., Valentine M. B., Raimondi S. C., Civin C. I., Ravindranath Y., Morris S. W. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene. Blood 1994; 84: 440a
   PubMed Web of Science ®Google Scholar
• Nucifora G., Birn D. J., Espinosa R., III, Erickson P., Le Beau M. M., Roulston D., McKeithan T. W., Drabkin H., Rowley J. D. Involvement of the AML1 gene in the (3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 1993; 81: 2728–2734
   PubMed Web of Science ®Google Scholar
• Nucifora G., Begy C. R., Erickson P., Drabkin H. A., Rowley J. D. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc. Natl. Acad. Sci. USA 1993; 90: 7784–7788
   PubMed Web of Science ®Google Scholar
• Nucifora G., Begy C. R., Kobayashi H., Roulston D., Claxton D., Pedersen-Bjergaard J., Parganas E., Ihle J. N., Rowley J. D. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl. Acad. Sci. USA 1994; 91: 4004–4008
   PubMed Web of Science ®Google Scholar
• Nucifora G., Rowley J. D. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21). Leukemia Lymphoma 1994; 14: 353–362
   PubMed Web of Science ®Google Scholar
• Mitani K., Ogawa S., Tanaka T., Miyoshi H., Kurokawa M., Mano H., Yazaki Y., Ohki M., Hirai H. Generation of the AMLI-EVI-I fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 1994; 13: 504–510
   PubMed Web of Science ®Google Scholar
• Gu Y., Nakamura T., Alder H., Prasas R., Canaani O., Cimino G., Croce C. M., Canaani E. The t(4; 11) chromosome translocation of human acute leukemia fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992; 71: 701–708
   PubMed Web of Science ®Google Scholar
• Morrissey J., Tkachuk D. C., Milatovich A., Francke U., Link M., Cleary M. L. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias. Blood 1993; 81: 1124–1131
   PubMed Web of Science ®Google Scholar
• Domer P. H., Fakharzadeh S. S., Chen C. S., Jockel J., Johansen L., Silverman G. A., Kersey J. H., Korsmeyer S. J. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc. Natl. Acad. Sci. USA 1993; 90: 7884–7888
   PubMed Web of Science ®Google Scholar
• Hilden J. M., Kersey J. H. The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4; 11) acute leukemia: Molecular and clinical studies. Leukemia Lymphoma 1994; 14: 189–195
   PubMed Web of Science ®Google Scholar
• Golub T. R., Barker G. F., Lovett M., Gilliland D. G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77: 307–316
   PubMed Web of Science ®Google Scholar
• Redner R. L., Rush E. A., Faas S., Rudert W. A., Corey S. J. The t(5; 17) translocation in acute promyelocytic leukemia generates a nucleophosmin-RARa fusion transcript. Blood 1994; 84: 375a
   Web of Science ®Google Scholar
• von Lindern M., Poustka A., Lerach H., Grosveld G. The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. Mol. Cell. Biol. 1990; 10: 4016–4026
   PubMed Web of Science ®Google Scholar
• von Lindern M., Fornerod M., van Baal S., Jaegle M., De Wit T., Buijs A., Grosveld G. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek, can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol. Cell. Biol. 1992; 12: 1687–1697
   PubMed Web of Science ®Google Scholar
• von Lindern M., van Baal S., Wiegant J., Raap A., Hagemeijer A., Grosveld G. can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3′ half to different genes: Characterization of the set gene. Mol. Cell. Biol. 1992; 12: 3346–3355
   PubMed Web of Science ®Google Scholar
• Soekarman D., von Lindern M., Daenen S., De Jong B., Fonatsch C., Heinze B., Bartram C., Hagemeijer A., Grosveld G. The translocation (6;9)(p23;q34) shows consistent rearrangements of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992; 79: 2990–2997
   PubMed Web of Science ®Google Scholar
• Soekarman D., von Lindern M., van der Plas D. C., Selleri L., Bartram C. R. I., Martiat P., Culligan D., Padua R. A., Hasper-Voogt K. P., Hagemeijer A., Grosveld G. Dek-Can rearrangement in translocation (6;9)(p23;q34). Leukemia 1992; 6: 489–494
   PubMed Web of Science ®Google Scholar
• Prasad R., Gu Y., Alder H., Nakamura T., Canaani O., Saito H., Huebner K., Gale R. P., Nowell P. C., Kuriyama K., Miyazaki Y., Croce C. M., Canaani E. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with t(6;1 1) chromosome translocation. Cancer Res. 1993; 53: 5624–5628
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 1991; 88: 10431–10434
   PubMed Web of Science ®Google Scholar
• Miyoshi H., Kozu T., Shimizu K., Enomoto K., Maseki N., Kaneko Y., Kamada N., Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 1993; 12: 2715–2721
   PubMed Web of Science ®Google Scholar
• Erickson P., Gao J., Chang K. S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowley J., Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AMLf1ETO, with similarity to Drosophila segmentation gene. runt. Blood 1992; 80: 1825–1831
   PubMed Web of Science ®Google Scholar
• Ohki M. Molecular basis of the t(8;21) translocation in acute myeloid leukaemia. Semin. Cancer Biol. 1993; 4: 369–375
   PubMed Web of Science ®Google Scholar
• Tighe J. E., Daga A., Calabi F. Translocation breakpoints are clustered on both chromosome 8 and chromosome 21 in the t(8;21) of acute myeloid leukemia. Blood 1993; 81: 592–596
   PubMed Web of Science ®Google Scholar
• Nakamura T., Alder H., Gu Y., Prasad R., Canaani O., Kamada N., Gale R. P., Lange B., Crist W. M., Nowell P. C., Croce C. M., Canaani E. Genes on chromosomes 4, 9 and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc. Natl. Acad. Sci. USA 1993; 90: 4631–4635
   PubMed Web of Science ®Google Scholar
• De Klein A., Geurts van Kessel A., Grosveld G., Bartram C. R., Hagemejier A., Bootsma D., Spurr N. K., Heisterkamp N., Groffen J., Stephenson J. R. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelo-cytic leukaemia. Nature 1982; 300: 765–767
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Stephenson J. R., Groffen J., Hansen P. F., De Klein A., Bartram C. R., Grosveld G. Localization of the c-abl oncogene adjacent to a translocation breakpoint in chronic myelocytic leukaemia. Nature 1983; 306: 239–242
   PubMed Web of Science ®Google Scholar
• Groffen J., Stephenson J. R., Heisterkamp N., De Klein A., Bartram C. R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R. P., Canaani E. Fused transcript of abl, bcr genes in chronic myelogenous leukaemia. Nature 1985; 315: 550–554
   PubMed Web of Science ®Google Scholar
• Ben-Neriah Y., Daley G. Q., Mes-Masson A. M., Witte O. N., Baltimore D. The chronic myelogenous leukemia-specific p210 protein is the product of the bcr/abl hybridgene. Science 1986; 233: 212–214
   PubMed Web of Science ®Google Scholar
• Hermans A., Heisterkamp N., von Lindern M., van Baal S., Meijer D., van der Plas D., Wiedeman L. M., Groffen J., Bootsma D., Grosveld G. Unique fusion of bcr and c-abl genes in Philadelphia chromosome-positive acute lym-phoblastic leukemia. Cell 1987; 51: 33–40
   PubMed Web of Science ®Google Scholar
• Kurzrock R., Gutterman J. K., Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemia. N. Engl. J. Med. 1988; 319: 990–998
   PubMed Web of Science ®Google Scholar
• Ayton P., Bernard O. A., Chaplin T., Saha V., Della Valle V., Hillion J., Gregorini A., Lillington D., Berger R., Young B. D. Molecular cloning of the gene (AF10) involved in the t(10;11)(p12;q23) translocation in acute leukaemia reveals a new class of conserved zinc fingdleucine zipper proteins. Blood 1994; 84: 230a
   Google Scholar
• Chen Z., Brand N. J., Chen A., Chen S. J., Tong J. H., Wang Z. Y., Waxman S., Zelent A. Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 1993; 12: 1161–1167
   PubMed Web of Science ®Google Scholar
• Chen Z., Guidez F., Rousselot P., Agadir A., Chen S. J., Wang Z. Y., Degos L., Zelent A., Waxman S., Chomienne C. PLZF-RARα fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc. Natl. Acad. Sci. USA 1993; 91: 1178–1182
   Web of Science ®Google Scholar
• Gillard E. F., Solomon E. Acute promyelocytic leukaemia and the t(15:17) translocation. Semin. Cancer Biol. 1993; 4: 359–367
   PubMed Web of Science ®Google Scholar
• Prasad R., Leshkovitz D., Gu Y., Alder H., Nakamura T., Saito H., Huebner K., Berger R., Croce C. M., Canaani E. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. Proc. Natl. Acad. Sci. USA 1994; 91: 8107–8111
   PubMed Web of Science ®Google Scholar
• Tkachuk D. C., Kohler S., Cleary M. L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992; 71: 691–700
   PubMed Web of Science ®Google Scholar
• Thirman M. J., Levitan D. A., Kobayashi H., Simon M. C., Rowley J. D. Cloning of a novel gene, ELL, that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Blood 1994; 84: 230a
   Web of Science ®Google Scholar
• De Thé H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• De Thé H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PML-RARα fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675–684
   PubMed Web of Science ®Google Scholar
• Borrow J., Goddard A. D., Sheer D., Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–1580
   PubMed Web of Science ®Google Scholar
• Lemons R. S., Eilender D., Waldmann R. A., Robentisch M., Frej A. K., Ledbetter D. M., Willmann C., McConnel P. Cloning and characterization of the t(15;17) translocation breakpoint region in acute promyelocytic leulkemia. Genes Chromosomes Cancer 1990; 2: 79–87
   PubMed Web of Science ®Google Scholar
• Alcalay M., Zangrilli D., Pandolfi P. P., Longo L., Mencarelli A., Giacomucci A., Rocchi M., Biondi A., Rambaldi A., Lo Coco F., Diverio D., Donti E., Grignani F., Pelicci P. G. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor α locus. Proc. Natl. Acad. Sci. USA 1991; 88: 1977–1981
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W. H., Jr, Umesono K., Warrell R. P., Jr, Frankel S. R., Murty V. V. V.S., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• Warrell R. P., De Thé H., Wang Z. Y., Degos L. Acute promyelocytic leukemia. N. Engl. J. Med. 1993; 329: 177–189
   PubMed Web of Science ®Google Scholar
• Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfo P. P., Donti E., Biondi A., Lo Coco F., Grignani F., Pelicci P. G. Acute promyelocytic leukemia: From genetics to treatment. Blood 1994; 83: 10–25
   PubMed Web of Science ®Google Scholar
• Lavau C., Dejean A. The t(15; 17) translocation in acute promyelocytic leukemia. Leukemia 1994; 8: 1615–1621
   PubMed Web of Science ®Google Scholar
• Liu P., Turlé S. A., Hajra A., Claxton D. F., Marlton P., Freedman M., Sicilianso M. J., Collins F. S. Fusion between transcription factor CBFβ/PEBP2β and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041–1044
   PubMed Web of Science ®Google Scholar
• Liu P., Claxton D. F., Marlton P., Hajra A., Siciliano J., Freedman M., Chandrasekharappa S. C., Yanagisawa K., Stallings R. L., Collins F. S., Siciliano M. J. Identification of yeast artificial chromosomes containing the inversion 16 p-arm breakpoint associated with acute myelomono-cytic leukemia. Blood 1993; 82: 716–721
   PubMed Web of Science ®Google Scholar
• Dauwerse J. G., Wessels J. W., Giles R. H., Wiegant J., van der Reijden B. A., Fugazza C., Jumelet E. A., Smit E., Baas F., Raap A. K., Hagemeijer A., Beverstock G. C., Vari Ommen G. J. B., Breuning M. H. Cloning the breakpoint cluster region of the inv(16) in acute myelomonocytic leukemia M4 Eo. Hum. Mol. Genet. 1993; 2: 1527–1534
   PubMed Web of Science ®Google Scholar
• Rabbits T. H., Forster A., Larson R., Nathan P. Fusion of the dominant negative trnnscription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nature Genet. 1993; 4: 175–180
   PubMed Web of Science ®Google Scholar
• Ichikawa H., Shimizu K., Hayashi Y., Ohki M. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res. 1994; 54: 2865–2868
   PubMed Web of Science ®Google Scholar
• Hunger S. P., Ohyashiki K., Toyama K., Cleary M. L. HLF, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev. 1992; 6: 1608–1620
   PubMed Web of Science ®Google Scholar
• Inaba T., Roberts W. M., Shapiro L. H., Jolly K. W., Raimondi S. C., Smith S. D., Look T. A. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 1992; 257: 531–534
   PubMed Web of Science ®Google Scholar
• Corral J., Forster A., Thompson S., Lampert F., Kaneko Y., Slater R., Kroes W. G., van der Schoot C. E., Ludwig W. D., Karpas A., Pocock C., Cotter F., Rabbitts T. H. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc. Natl. Acad. Sci. USA 1993; 90: 8538–8542
   PubMed Web of Science ®Google Scholar
• Parry P., Wei Y., Evans G. Cloning and characterization of the t(X; 11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family. Gene Chromosomes Cancer 1994; 11: 79–84
   PubMed Web of Science ®Google Scholar
• Latchman D. S. Eukaryotic transcription factors. Biochem. J. 1990; 270: 281–285
   PubMed Web of Science ®Google Scholar
• Mitchell P. J., Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989; 245: 371–373
   PubMed Web of Science ®Google Scholar
• Nichols J., Nimer S. D. Transcription factors, translocations, and leukemia. Blood 1992; 80: 2953–2963
   PubMed Web of Science ®Google Scholar
• Van Dongen J. J. M., Breit T. M., Adriaansen H. J., Beishuizen A., Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6(Suppl. 1)47–59
   PubMed Web of Science ®Google Scholar
• Campana D. Monitoring minimal residual disease in acute leukemia: Expectations, possibilities and initial clinical results. Int. J. Clin. Lab. Res. 1994; 24: 132–138
   PubMedGoogle Scholar
• Bentz M., Döhner H., Cabot G., Lichter P. Fluorescence in situ hybridization in leukemias: “The FISH are spawning”. Leukemia 1994; 8: 1447–1452
   PubMed Web of Science ®Google Scholar
• Hughes T. P., Ambrosetti A., Barbu V., et al. Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: Report of the Third Workshop of the Molecular Biology/BMT Study Group. Leukemia 1991; 5: 448–451
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Blume K. G. The use of the polymerase chain reaction for the detection of minimal residual malignant disease. Blood 1991; 78: 255–258
   PubMed Web of Science ®Google Scholar
• Potter M. N., Cross N. C. P., Van Dongen J. J. M., Saglio G., Oakhill A., Bartram C. R., Goldman J. M. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: An updated meeting report and review. Leukemia 1993; 7: 1302–1314
   PubMed Web of Science ®Google Scholar
• Bartram C. R. Detection of minimal residual leukemia by the polymerase chain reaction: Potential implications for therapy. Clin. Chim. Acta 1993; 217: 75–83
   PubMed Web of Science ®Google Scholar
• Biondi A., Rambaldi A. Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemia. Stem Cells 1994; 12: 394–401
   PubMed Web of Science ®Google Scholar
• Jonsson O. G., Kitchens R. L., Baer R. J., Buchanan G. R., Smith R. G. Rearrangements of the tal-l locus as clonal markers for T-cell acute lymphoblastic leukemia. J. Clin. Invest. 1991; 87: 2029–2035
   PubMed Web of Science ®Google Scholar
• Macintyre E., Smit L., Ritz J., Kirsch I. R., Strominger J. L. Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor αβ lineage. Blood 1992; 80: 1511–1520
   PubMed Web of Science ®Google Scholar
• Borkhardt A., Repp R., Harbott J., Keller C., Berner F., Ritterbach J., Lampert F. Frequency and DNA sequence of tal-I rearrangement in children with T-cell acute lymphoblastic leukemia. Ann. Hematol. 1992; 64: 305–308
   PubMed Web of Science ®Google Scholar
• Breit T. M., Beishuizen A., Ludwig W. D., Mol E. J., Adriaansen H. J., Van Wering E. R., Van Dongen J. J. M. tal-I deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual desease. Leukemia 1993; 7: 2004–2011
   PubMed Web of Science ®Google Scholar
• Janssen J. W. G., Ludwig W. D., Sterry W., Bartram C. R. SIL-TAL-I deletion in T-cell acute lymphoblastic leukemia. Leukemia 1993; 7: 1204–1210
   PubMed Web of Science ®Google Scholar
• Kagan J., Finger L. R., Besa E., Croce C. M. Detection of minimal residual disease in leukemic patients with the t(10;14)(q24;q11) chromosomal translocation. Cancer Res. 1990; 50: 5240–5244
   PubMed Web of Science ®Google Scholar
• Rimokh R., Berger F., Delsol G., Digonnet I., Rouault J. P., Tigaud J. D., Gadoux M., Coiffier B., Bryon P. A., Magaud J. P. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994; 83: 1871–1875
   PubMed Web of Science ®Google Scholar
• Molot R. J., Meeker T. C., Wittwer C. T., Perkins S. L., Segal G. H., Masih A. S., Braylan R. C., Kjeldsberg C. R. Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 1994; 83: 1626–1631
   PubMed Web of Science ®Google Scholar
• Komatsu H., Iida S., Yamamoto K., Mikuni C., Nitta M., Takahashi T., Ueda R., Seto M. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-I gene. Blood 1994; 84: 1226–1231
   PubMed Web of Science ®Google Scholar
• Lee M. S., Chang K. S., Cabanillas F., Freireich E. J., Trujillo J. M., Stass S. A. Detection of minimal residual cells canying the t(14;18) by DNA sequence amplification. Science 1987; 237: 175–178
   PubMed Web of Science ®Google Scholar
• Creszenzi M., Seto M., Herzig G. P., Weiss P. D., Griffith R. C., Korsmeyer S. I. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc. Natl. Acad. Sci. USA 1988; 85: 4869–4873
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson M., Raffeld M., Cohen P., Cossman J. Detection of occult follicular lymphoma by specific DNA amplification. Blood 1988; 72: 1822–1825
   PubMed Web of Science ®Google Scholar
• Ngan B. Y., Nourse J., Cleary M. L. Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 1989; 73: 1759–1762
   PubMed Web of Science ®Google Scholar
• Pezzella F., Gatter K. C., Mason D. Y. Detection of 14; 18 chromosomal translocation in paraffin-embedded lymphoma tissue. Lancet 1989; i: 779–780
   Google Scholar
• Price C. G. A., Meerabux J., Murtagh S., Cotter F. E., Rohatiner A. Z. S., Young B. D., Lister T. A. The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J. Clin. Oncol. 1991; 9: 1527–1532
   PubMed Web of Science ®Google Scholar
• Gribben I. G., Freedman A. S., Woo S. D., Blake K., Shu R. S., Freeman G., Longtine J. A., Pinkus G. S., Nadler L. M. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275–3280
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Freedman A. S., Neuberg D., Roy D. C., Blake K. W., Woo S. D., Grossbard M. L., Rabinowe S. N., Coral F., Freeman G. J., Ritz J., Nadler L. M. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 1991; 325: 1525–1533
   PubMed Web of Science ®Google Scholar
• Lambrechts A. C., De Ruiter P. E., Dorssers L. C. J., van't Veer M. B. Detection of residual disease in translocation (14;18) positive non-Hodgkin's lymphoma, using the polymerase chain reaction: A comparison with conventional staging methods. Leukemia 1992; 6: 29–34
   PubMed Web of Science ®Google Scholar
• Gribben J. G., Neuberg D., Freedman A. S., Gimmi C. D., Pesek K. W., Barber M., Saporito L., Woo S. D., Coral F., Spector N., Rabinowe S. N., Grossbard M. L., Ritz J., Nadler L. M. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449–3457
   PubMed Web of Science ®Google Scholar
• Berinstein N. L., Jamal H. H., Kuzniar B., Klock R. J., Reis M. D. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment. Leukemia 1993; 7: 113–119
   PubMed Web of Science ®Google Scholar
• Finke J., Slanina J., Lange W., Dölken G. Persistence of circulating t(14; 18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J. Clin. Oncol. 1993; 11: 1668–1673
   PubMed Web of Science ®Google Scholar
• Lambrechts A. C., Hupkes P. E., Dorssers L. C. J., Van't Veer M. B. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular Non-Hodgkin's lymphoma. Blood. 1993; 82: 2510–2516
   PubMed Web of Science ®Google Scholar
• Soubeyran P., Cabanillas F., Lee M. S. Analysis of the expression of the hybrid gene bcl-2/IgH in follicular lymphoma. Blood 1993; 81: 122–127
   PubMed Web of Science ®Google Scholar
• Lambrechts A. C., Hupkes P. E., Dorssers L. C. J., Van't Veer M. B. Clinical significance of 1.(14;18)-positive cells in the circulation of patients with stage III or IV follicular Non-Hodgkin's lymphoma during first remission. J. Clin. Oncol. 1994; 12: 1541–1546
   PubMed Web of Science ®Google Scholar
• Hunger S. P., Galili N., Carroll A. J., Crist W. M., Link M. P., Cleary M. L. The t(1;19)(q23;p13) results in consistent fusion of E2A, PEXI coding sequences in acute lymphoblastic leukemias. Blood 1991; 77: 687–693
   PubMed Web of Science ®Google Scholar
• Izraeli S., Lion T. Multiprimer-PCR for screening of genetic abnormalities in acute lymphoblastic leukaemia. Brit. J. Haematol. 1991; 79: 645–647
   PubMed Web of Science ®Google Scholar
• Izraeli S., Janssen J. W.G., Haas O. A., Harbott J., Brok-Simoni F., Walther J. U., Kovar H., Henn T., Ludwig W. D., Reiter A., Rechavi G, Bartram C. R., Gadner H., Lion T. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: A comparison between cyto-genetic and polymerase chain reaction analyses. Leukemia 1993; 7: 671–678
   PubMed Web of Science ®Google Scholar
• Privitera E., Kamps M. P., Hayashi Y., Inaba T., Shapiro L. H., Raimondi S. C., Behm F., Hendershot L., Carroll A. J., Baltimore D., Look A. T. Different molecular consequences of the 1; 19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia. Blood 1992; 79: 1781–1788
   PubMed Web of Science ®Google Scholar
• Biondi A., Rambaldi A., Rossi V., Elia L., Caslini C., Basso G., Battista R., Barbui T., Mandelli F., Masera G., Croce C., Canaani E., Cimino G. Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood 1993; 82: 2943–2947
   PubMed Web of Science ®Google Scholar
• Hilden J. M., Chen C. S., Moore R., Frestedt J., Kersey J. H. Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia. Cancer Res. 1993; 53: 3853–3856
   PubMed Web of Science ®Google Scholar
• Downing J. R., Head D. R., Raimondi S. C., Carroll A. J., Curcio-Brint A. M., Motroni T. A., Hulshof M. G., Pullen D. J., Domer P. H. The der(II)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21, q23)-containing acute lymphoblastic leukemia. Blood 1994; 83: 330–335
   PubMed Web of Science ®Google Scholar
• Yamamoto K., Seto M., Iida S., Komatsu H., Kamada N., Kojima S., Kodera Y., Nakazawa S., Saito H., Takahashi T., Ueda R. A reverse transcriptase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood 1994; 83: 2912–2921
   PubMed Web of Science ®Google Scholar
• Griesinger F., Elfers H., Ludwig W. D., Falk M., Rieder H., Harbott J., Lampert F., Heinze B., Hoelzer D., Thiel E., Riehm H., Wörmann B., Fonatsch C., Hiddemann W. Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11). Leukemia 1994; 8: 542–548
   PubMed Web of Science ®Google Scholar
• Borkhardt A., Repp R., Haupt E., Brettreich S., Buchen U., Gossen R., Lampert F. Molecular analysis of MLL-1/AF4 recombination in infant acute lymphoblastic leukemia. Leukemia 1994; 8: 549–553
   PubMed Web of Science ®Google Scholar
• Repp R., Borkhardt A, Haupt E., Kreuder J., Brettreich S., Hammermann J., Nishida K., Lampert F. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia 1994, in press
   PubMed Web of Science ®Google Scholar
• Janssen J. W. G., Ludwig W. D., Borkhardt A., Spaldinger U., Fonatsch C., Hossfeld D. K., Harbot J., Schulz A. S., Reiter A., Hoelzer D., Bartram C. R. Pre-pre-B acute lymphoblastic leukemia: High frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission. Blood 1994, in press
   PubMed Web of Science ®Google Scholar
• Downing J. R., Head D R., Curcio-Brint A. M., Hulshof M. G., Motroni T. A., Raimondi S. C., Carroll A. J., Drabkin H. A., Willman C., Theil K. S., Civin C. I., Erickson F. An AMLI/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 1993; 81: 2860–2865
   PubMed Web of Science ®Google Scholar
• Kozu T., Miyoshi H., Shimizu K., Maseki N., Kaneko Y., Asou H., Kamada N., Ohki M. Junctions of the AMLI/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase: chain reaction. Blood 1993; 82: 1270–1276
   PubMed Web of Science ®Google Scholar
• Nucifora G., Birn D. I., Erickson P., Gao J., Le Beau M. M., Drabkin H., Rowley J. D. Detection of DNA rearrangements in the AML1, ETO loci and of, an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 1993; 81: 883–888
   PubMed Web of Science ®Google Scholar
• Nucifora G., Larson R. A., Rowley J. D. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1991; 82: 712–715
   Web of Science ®Google Scholar
• Chang K. S., Fan Y. H., Stass S. A., Estey E. H., Wang G., Trujillo J. M., Erickson P., Drabkin H. Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene 1919b; 8: 983–988
   Google Scholar
• Maruyama F., Yang P., Stass S. A., Cork A., Freireich E. J., Lee M. S., Chang K. S. Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia. Cancer Res. 1993; 53: 4449–4451
   PubMed Web of Science ®Google Scholar
• Maruyama F., Stass S. A., Estey E. H., Cork A., Hirano M., Ino T., Freichreich E. J., Yang P., Chang K. S. Detection of AMLI/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 1994; 8: 40–45
   PubMed Web of Science ®Google Scholar
• Kusec R., Laczika K., Knöbl P., Friedl J., Greinix H., Kahls P., Linkesch W., Schwarzinger I., Mitterbauer G., Purtscher B., Lechner O. A., Haas K., Jaeger U. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 1994; 8: 735–739
   PubMed Web of Science ®Google Scholar
• Zhang T., Hillion J., Tong J. H., Cao Q., Chen S. J., Berger R., Chen Z. AML-1 gene rearrangement and AML-1-ETO gene expression as molecular markers of acute myeloblastic leukemia with t(8;21). Leukemia 1994; 8: 729–734
   PubMed Web of Science ®Google Scholar
• Saunders M. J., Tobal K., Yin J. A. L. Detection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukaemia type M2 after chemotherapy or bone marrow transplantation. Leukemia Res. 1994; 18: 891–895
   PubMed Web of Science ®Google Scholar
• Lee M. S., Le Maistre A., Kantarjian H. M., Talpaz M., Freireich E. J., Trujillo J. M., Stass S. A. Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Blood 1989; 73: 2165–2170
   PubMed Web of Science ®Google Scholar
• Kawasaki E. S., Clark S. S., Coyne M. Y., Smith S. D., Champlin R., Witte O. N., McCormick F. P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified. in vitro. Proc. Natl. Acad. Sci. USA 1988; 85: 5698–5702
   PubMed Web of Science ®Google Scholar
• Dobrovic A., Trainor K. J., Morley A. A. Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction. Blood 1988; 72: 2063–2065
   PubMed Web of Science ®Google Scholar
• Hermans A., Gow J., Selleri L., von Lindern M., Hagemeijer A., Wiedemann L. M., Grosveld G. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 1988; 2: 628–633
   PubMed Web of Science ®Google Scholar
• Roth M. S., Antin J. H., Bingham E. L., Ginsburg D. Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 1989; 74: 882–885
   PubMed Web of Science ®Google Scholar
• Hooberman A. L., Carrino J. J., Leibowitz D., Rowley J. D., Le Beau M. M., Arlin Z. A., Westbrook C. A. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 1989; 86: 4259–4263
   PubMed Web of Science ®Google Scholar
• Morgan G. J., Hughes T., Janssen J. W. G., Gow J., Guo A. P., Goldman J. M., Wiedemann L. M., Bartram C. R. Polymerase chain reaction for detection of residual leukaemia. Lancet 1989; i: 928–929
   Google Scholar
• Gabert I., Thuret I., Lafage M., Carcassone Y., Maranchini D., Mannoni P. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone-marrow transplantation. Lancet 1989; ii: 1125–1127
   Google Scholar
• Lange W., Snyder D. S., Castro R., Rossi J. J., Blume K. G. Detection by enzymatic amplification of bcr-abl mRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia. Blood 1989; 73: 1735–1741
   PubMed Web of Science ®Google Scholar
• Bartram C. R., Janssen J. W. G., Schmidberger M., Lyons J., Arnold R. Minimal residual leukaemia in chronic myeloid leukaemia patients after T-cell depleted bone-marrow transplantation. Lancet 1989; i: 1260
   Google Scholar
• Delfau M. H., Kerckaert J. P., Collyn d'Hooghe M., Fenaux P., Lai J. L., Jouet J. P., Grandchamp B. Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 1990; 4: 1–5
   PubMed Web of Science ®Google Scholar
• Martiat P., Maisin D., Philippe M., Ferrant A., Michaux J. L., Cassiman J. J., Van Den Berghe H., Sokal G. Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers. Brit. J. Haematol. 1990; 75: 355–358
   PubMed Web of Science ®Google Scholar
• Sawyers C. L., Timson L., Kawasaki E. S., Clark S. S., Witte O. N., Champlin R. Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Proc. Natl. Acad. Sci. USA 1990; 87: 563–567
   PubMed Web of Science ®Google Scholar
• Kohler S., Galili N., Sklar J. L., Donlon T. A., Blume K. G., Cleary M. L. Expression of bcr-abl fusion transcripts following bone marrow transplantation for Philadelphia chromosome-positive leukemia. Leukemia 1990; 4: 541–547
   PubMed Web of Science ®Google Scholar
• Suryanarayan K., Hunger S. P., Kohler S., Carroll A. J., Crist W., Link M. P., Cleary M. L. Consistent involvement of the BCR gene by 9;22 breakpoints in pediatric acute leukemias. Blood 1991; 77: 324–330
   PubMed Web of Science ®Google Scholar
• Delage R., Soiffer R. J., Dear K., Ritz J. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood 1991; 78: 2759–2767
   PubMed Web of Science ®Google Scholar
• Hughes T. P., Morgan G. J., Martiat P., Goldman J. M. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 1991; 77: 874–878
   PubMed Web of Science ®Google Scholar
• Opalka B., Wandl U. B., Becher R., Kloke O., Nagel-Hiemke M., Moritz T., Beer U., Seeber S., Niederle N. Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant inter-feron α-2b alone or in combination with interferon γ. Blood 1991; 78: 2188–2193
   PubMed Web of Science ®Google Scholar
• Gehly G. B., Bryant E. M., Lee A. M., Kidd P. G., Thomas E. D. Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1991; 78: 458–465
   PubMed Web of Science ®Google Scholar
• Maurer J., Janssen J. W. G., Thiel E., Van Denderen J., Ludwig W. D., Aydemir Ü., Heinze B., Fonatsch C., Harbott J., Reiter A., Riehm H., Hoelzer D., Bartram C. R. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancer 1991; 337: 1055–1058
   PubMed Web of Science ®Google Scholar
• Roth M. S., Antin J. H., Ash R., Terry V. H., Gotlieb M., Silver S. M., Ginsburg D. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 1992; 79: 276–282
   PubMed Web of Science ®Google Scholar
• Bilhou-Nabera C., Viard F., Marit G., Gharbi M. J., Salzes S., Reiffers J., Broustet A., Bernard P. Complete cyto-genetic conversion in chronic myelocytic leukemia patients undergoing interferon α therapy: Follow-up with reverse polymerase chain reaction. Leukemia 1992; 6: 595–598
   PubMed Web of Science ®Google Scholar
• Pignon J. M., Henni T., Amselem S., Vidaud M., Duquesnoy P., Vernant J. P., Kuentz M., Cordonnier C., Rochant H., Goossens M. Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia 1990; 4: 83–86
   PubMed Web of Science ®Google Scholar
• Snyder D. S., Rossi J. J., Wang J. L., Sniecinski I. J., Slovak M. L., Wallace R. B., Forman S. J. Persistence of bcr-abl gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Transplantation 1991; 51: 1033–1040
   PubMed Web of Science ®Google Scholar
• Lee M. S., Kantarjian H., Talpaz M., Freireich E. J., Deisseroth A. B., Trujillo J. M., Stass S. A. Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood 1992; 79: 1920–1923
   PubMed Web of Science ®Google Scholar
• Lee M., Khouri I., Champlin R., Kantarjian H., Talpaz M., Trujillo J., Freireich E., Deisseroth A., Stass S. Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation. Brit. J. Haematol. 1992; 82: 708–714
   PubMed Web of Science ®Google Scholar
• Guerrasio A., Martinelli G., Saglio G., Rosso C., Zaccaria A., Rosti G., Testoni N., Ambrosetti A., Izzi T., Sessarego M., Frassoni F., Gasparini P., Chiamenti A., Di Bartolomeo P., Pignatti P. F. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: Low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants. Leukemia 1992; 6: 507–512
   PubMed Web of Science ®Google Scholar
• Lion T., Izraeli S., Henn T., Gaiger A., Mor W., Gadner H. Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction. Leukemia 1992; 6: 495–499
   PubMed Web of Science ®Google Scholar
• Miyamura K., Tahara T., Tanimoto M., Morishita Y., Kawashima K., Morishima Y., Saito H., Tsuzuki S., Takeyama K., Kodera Y., Matsuyama K., Hirabayashi N., Yamada H., Naito K., Imai K., Sakamaki H., Asai O., Mizutani S. Long persistence bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: A study of 64 patients. Blood 1993; 81: 1089–1093
   PubMed Web of Science ®Google Scholar
• Cross N. C. P., Feng L., Bungey J., Goldman J. M. Minimal residual disease after bone marrow transplant for chronic myeloid leukemia detected by the polymerase chain reaction. Leukemia Lymphoma 1993; 11 Suppl. 1: 39–43
   PubMed Web of Science ®Google Scholar
• Gaiger A., Lion T., Kalhs P., Mitterbauer G., Henn T., Haas O., Födinger M., Kier P., Forstinger C., Quehenberger P., Hinterberger W., Jäger U., Linkesch W., Mannhalter C., Lechner K. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT). Leukemia 1993; 7: 1766–1772
   PubMed Web of Science ®Google Scholar
• Cross N. C. P., Melo J. V., Feng L., Goldman J. M. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186–189
   PubMed Web of Science ®Google Scholar
• Talpaz M., Estrov Z., Kantarjian H., Ku S., Foteh A., Kurzrock R. Persistence of dormant leukemic progenitors during interferon-induced remission in (chronic myelogenous leukemia—Analysis by polymerase chain reaction of individual colonies. J. Clin. Invest. 1994; 94: 1383–1389
   PubMed Web of Science ®Google Scholar
• Radich J. P., Kopecky K. J., Boldt D. H., Head D., Slovak M. L., Babu R., Kirk J., Lee A., Kessler P., Appelbaum F., Gehly G. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia 1994; 8: 1688–1695
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Avvisati G., Diverio D., Petti M. C., Alcalay M., Pandolfi P. P., Zangrilli D., Biondi A., Rambaldi A., Moleti M. L., Mandelli F., Pelicci P. G. Mlolecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemia. Blood 1991; 77: 1657–1659
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Diverio D., Pandolfi P. P., Biondi A., Rossi V., Avvisati G., Rambaldi A., Arcese W., Petti M. C., Meloni G., Mandelli F., Grignani F., Masera G., Barbui T., Pelicci P. G. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancer 1992; 340: 1437–1438
   PubMed Web of Science ®Google Scholar
• Chang K. S., Lu J., Wang G., Trujillo J. M., Estey E., Cork A., Chu D. T., Freireich E. J., Stass S. A. The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: Targets for the detection of minimal residual disease by the polymerase chain reaction. Blood 1992; 79: 554–558
   PubMed Web of Science ®Google Scholar
• Biondi A., Rambaldi A., Pandolfi P. P., Rossi V., Giudici G., Alcalay M., Lo Coco F., Diverio D., Pogliani E. M., Lanzi E. M., Mandelli F., Masera G., Barbui T., Pelicci P. G. Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992; 80: 492–497
   PubMed Web of Science ®Google Scholar
• Castaigne S., Balitrand N., De Thé H., Dejean A., Degos L., Chomienne C. A PML/retinoic acid receptor α fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79: 3110–3115
   PubMed Web of Science ®Google Scholar
• Borrow J., Goddard A. D., Gibbons B., Katz F., Swirsky D., Fioretos T., Dube I., Wintield D. A., Kingston J., Hagemeijer A., Rees J. K. H., Lister T. A., Solomon E. Diagnosis of acute promyelocytic leukaemia by RT-PCR: Detection of PML-RARA, RARA-PML fusion transcripts. Brit. J. Haematol. 1992; 85: 529–540
   Web of Science ®Google Scholar
• Miller W. H., Jr, Kakizuka A., Frankel S. R., Warrell R. P., Jr, De Blasio A., Levine K., Evans R. M., Dmitrovsky E. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA. 1992; 89: 2694–2698
   PubMed Web of Science ®Google Scholar
• Chen S. J., Chen Z., Chen A., Tong J. H., Dong S., Wang Z. Y., Waxman S., Zelent A. Occurrence of distinct PML-RAR-α fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. Oncogene 1992; 7: 1223–1232
   PubMed Web of Science ®Google Scholar
• Miller W. H., Jr, Levine K., De Blasio A., Frankel S., Dmitrovsky E., Warrell R. P., Jr. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-α fusion mRNA. Blood 1993; 82: 1689–1694
   PubMed Web of Science ®Google Scholar
• Ikeda K., Sasaki K., Tasaka T., Nagai M., Kawanishi K., Takahara J., Irino S. Reverse transcriptase-polymerase chain reaction for PML-RARα fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection. Leukemia 1993; 7: 544–548
   PubMed Web of Science ®Google Scholar
• Huang W., Sun G. L., Li X. S., Cao Q., Lu Y., Jang G. S., Zhang F. Q., Chai J. R., Wang Z. Y., Waxman S., Chen Z., Chen S. J. Acute promyelocytic leukemia: Clinical relevance of two major PML-RARα isoforms and deteclion of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse. Blood 1993; 82: 1264–1269
   PubMed Web of Science ®Google Scholar
• Diverio D., Pandolfi P P., Biondi A., Avvisati G., Petti M. C., Mandelli F., Pelicci P. G., Lo Coco F. Absence of reverse transcriptase-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission. Blood 1993; 82: 3556–3559
   PubMed Web of Science ®Google Scholar
• Laczika K., Mitterbauer G., Korninger L., Knöbl P., Schwarzinger I., Kapiotis S., Haas O. A., Kyrle P. A., Pont J., Oehler L., Purtscher B., Thalhammer F., Lechner K., Jaeger U. Rapid achievement of PML-RARα polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocylic leukemia: A pilot study. Leukemia 1994; 8: 1–5
   PubMed Web of Science ®Google Scholar
• Kominger L., Knobl P., Laczika K., Mustafa S., Quehenberger P., Schwarzinger I., Lechner K., Jaeger U., Mannhalter C. PML-RAR alpha PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2–3 months. Brit J. Haematol. 1994; 88: 427–431
   PubMed Web of Science ®Google Scholar
• Claxton D F., Liu P., Hsu H. B., Marlton P., Hester J., Collins F., Deisseroth A. B., Rowley J. D., Siciliano M. J. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelsogenous leukemia. Blood 1994; 83: 1750–1756
   PubMed Web of Science ®Google Scholar
• Hébert J., Cayuela J. M., Daniel M. T., Berger R., Sigaux F. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplificiation. Blood 1994; 84: 2291–2296
   PubMed Web of Science ®Google Scholar
• Devaraj P. E., Forono L., Sekhar M., Butler T., Wright F., Mehta A., Samson D., Prentice H. G., Hoffbrand A. V., Secker-Walker L. E2A/HLF fusion cDNAs and the use of RT-PCR for the detection of minimal residual disease in t(17; 19)(q22;p13) acute lymphoblastic leukemia. Leukemia 1994; 8: 1131–1138
   PubMed Web of Science ®Google Scholar
• Hunger S. P., Devaraj P. E., Foroni L., Secker-Walker L. M., Cleary M. L. Two types of genomic rearrangements create alternative E2A-HILF fusion proteins in t(17;19)-ALL. Blood 1994; 83: 2970–2977
   PubMed Web of Science ®Google Scholar
• Drexler H. G., MacLeod R. A. F., Quentmeier H., Steube K. DSM Catalogue of Human and Animal Cell Lines, Fourth Edition. Braunschweig, Germany 1994
   Google Scholar
• Drexler H. G. Leukemia cell lines: In vitro models for the study of chronic myeloid leukemia. Leukemia Res. 1994; 18: 919–927
   PubMed Web of Science ®Google Scholar
• Drexler H. G., Gignac S. M., Miriowada J. Hematopoietic cell lines. Atlas of Human Tumor Cell Lines, R. J. Hay, J. G. Park, A. Gazdar. Academic Press, Orlando 1994; 213–250
   Google Scholar
• Hu Z. B., Quentmeier H., MacLeod R. A. F., Uphoff C. C., Drexler H. G. Cell lines as in vitro mode15 of acute promyelocytic leukemia. Leukemia Lymphoma 1994, submitted
   Google Scholar
• Saiki R. K., Scharf S., Faloona F., Mullis K. B., Horn G. T., Erlich H. A., Arnheim N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350–1354
   PubMed Web of Science ®Google Scholar
• Lee M. S., Chang K. S., Freireich E. J., Kantarjian H. M., Talpaz M., Trujillo J. M., Stass S. A. Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction. Blood 1988; 72: 893–897
   PubMed Web of Science ®Google Scholar
• Limpens J., De Jong D., van Krieken J. H. J.M., Price C. G. A., Young B. D., van Ommen G. J. B., Kluin P. M. Bcl-2/Jh rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991; 6: 2271–2276
   PubMed Web of Science ®Google Scholar
• Aster J. C., Kobayashi Y., Shiota M., Mori S., Sklar J. Detection of the t(14: 18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am. J. Pathol. 1992; 141: 291–299
   PubMed Web of Science ®Google Scholar
• Liu Y., Hernandez A. M., Shibata D., Cortopassi G. A. BCL2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. USA 1994; 91: 8910–8914
   PubMed Web of Science ®Google Scholar
• Kluin P. M., Stad R., Vos C., Limpens J., De Vlaam C., De Jong D., van Ommen G. J. B., Schuuring E. Lymphoma associated translocation t(14; 18) in blood B-cells of normal individuals. Blood 1994; 84: 521a
   Web of Science ®Google Scholar
• Kita K., Shirakawa S., Kamada N., the Japanese Cooperative Group of Leukemia/Lymphoma. Cellular characteristics of acute myeloblastic leukemia associated with t(8;21)(q22;q22). Leukemia Lymphoma. 1994; 13: 229–234
   PubMed Web of Science ®Google Scholar
• Melo J. V., Gordon D. E., Cross N. C. P., Goldman J. M. The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood 1993; 81: 158–165
   PubMed Web of Science ®Google Scholar
• Mills K. I., Benn P., Birnie G. D. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. Blood 1991; 78: 1155–1161
   PubMed Web of Science ®Google Scholar
• Hughes T., Janssen J. W. G., Morgan G., Martiat P., Saglio G., Pignon J. M., Pignatti F. P., Mills K., Keating A., Gluckman E., Bartram C. R., Goldman J. M. False-positive results with PCR to detect leukaemia-specific transcript. Lancet 1990; i: 1037–1038
   Web of Science ®Google Scholar
• Pichert G., Ritz J. Clinical significance of bcr-abl gene rearrangement detected by the polymerase chain reaction after al-logeneic bone marrow transplantation in chronic myelogenous leukemia. Leukemia Lymphoma 1993; 10: 1–8
   PubMed Web of Science ®Google Scholar
• Thompson J. D., Brodsky I., Yunis J. J. Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation. Blood 1992; 79: 1629–1635
   PubMed Web of Science ®Google Scholar
• Thirman M. J., Gill H. J., Burnett R. C., Mbangkollo D., McCabe N. R., Kobayashi H., Ziemin-van der Poel S., Kaneko Y., Morgan R., Sandberg A. A., Chaganti R. S. K., Larson R. A., Le Beau M. M., Diaz M. O., Rowley J. D. Rearrangemant of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocation?. N. Engl. J. Med. 1993; 329: 909–914
   PubMed Web of Science ®Google Scholar
• Alcalay M., Zangrilli D., Fagioli M., Pandolfi P. P., Mencarelli A., Lo Coco F., Biondi A., Grignani F., Pelicci P. G. Expression pattern of the RARα-PML fusion gene in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA 1992; 89: 4840–4844
   PubMed Web of Science ®Google Scholar
• Geng J. P., Tong J. H., Dong S., Wang Z. Y., Chen S. J., Chen Z., Zelent A., Berger R., Larsen C. J. Localization of the chromosome 15 breakpoints and expression of multiple PML-RARα transcripts in acute promyelocytic leukemia: A study of 28 Chinese patients. Leukemia 1993; 7: 20–26
   PubMed Web of Science ®Google Scholar
• Claxton D. F., Reading C. L., Nagarajan L., Tsujimoto Y., Andersson B. S., Estey E., Cork A., Huh Y. O., Trujillo J., Deisseroth A. B. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 1992; 80: 582–586
   PubMed Web of Science ®Google Scholar
• Diverio D., Pandolfi P. P., Rossi V., Biondi A., Pelicci P. G., Lo Coco F. Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR. Leukemia 1994; 8: 1105–1107
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Pelicci P. G., Biondi A. Clinical relevance of the PML/RAR-α gene rearrangement in acute promyelocytic leukaemia. Leukemia Lymphoma 1994; 12: 327–332
   PubMed Web of Science ®Google Scholar
• Johnson P. W. M., Lister T. A. Can the polymerase chain reaction be used to direct therapy?. Leukemia Lymphoma 1993; 10 Suppl: 151–152
   PubMedGoogle Scholar
• Lion T. Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. Bone Marrow Transplant. 1994; 14: 505–509
   PubMed Web of Science ®Google Scholar
• Cross N. C. P., Feng L., Chase A., Bungey J., Hughes T. P., Goldman J. M. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929–1936
   PubMed Web of Science ®Google Scholar
• Vanrhee F., Lin F., Cross N. C. P., Reid C. D. L., Lakhani A. K. V., Szydlo R. M., Goldman J. M. Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Bone Marrow Transplant. 1994; 14: 609–612
   PubMed Web of Science ®Google Scholar